Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis.

Mincu, Raluca I

Cardiovascular Adverse Events Associated With BRAF and MEK Inhibitors: A Systematic Review and Meta-analysis. [electronic resource] - JAMA network open 08 2019 - e198890 p. digital

Publication Type: Journal Article; Meta-Analysis; Systematic Review

2574-3805

10.1001/jamanetworkopen.2019.8890 doi


Acrylonitrile--analogs & derivatives
Adult
Aged
Aged, 80 and over
Aniline Compounds--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Cardiovascular Diseases--chemically induced
Female
Humans
Male
Melanoma--drug therapy
Middle Aged
Protein Kinase Inhibitors--therapeutic use
Proto-Oncogene Proteins B-raf--therapeutic use
Randomized Controlled Trials as Topic
Skin Neoplasms--drug therapy
Young Adult